Human anti-murine antibody responses in ovarian cancer patients undergoing radioimmunotherapy with the murine monoclonal antibody OC-125
- 1 August 1990
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 38 (2) , 244-248
- https://doi.org/10.1016/0090-8258(90)90049-q
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Intraperitoneal radiolabeled OC125 in patients with advanced ovarian cancerGynecologic Oncology, 1989
- Intraperitoneal radioimmunotherapy for ovarian cancer: Pharmacokinetics, toxicity, and efficacy of I-131 labeled monoclonal antibodiesInternational Journal of Radiation Oncology*Biology*Physics, 1989
- The treatment of intraperitoneal malignant disease with monoclonal antibody guided 131I radiotherapyBritish Journal of Cancer, 1988
- An assay for the detection of human anti-murine immunoglubulins in the presence of CA125 antigenJournal of Immunological Methods, 1988
- Antibody-guided irradiation of advanced ovarian cancer with intraperitoneally administered radiolabeled monoclonal antibodies.Journal of Clinical Oncology, 1987
- OKT3 MONOCLONAL ANTIBODY PLASMA LEVELS DURING THERAPY AND THE SUBSEQUENT DEVELOPMENT OF HOST ANTIBODIES TO OKT3Transplantation, 1986
- Radioimmunodetection of Cutaneous T-Cell Lymphoma with111In-Labeled T101 Monoclonal AntibodyNew England Journal of Medicine, 1986
- Specific detection of anti-idiotypic immune responses in cancer patients treated with murine monoclonal antibodyJournal of Immunological Methods, 1985
- Determination of the immunoreactive function of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excessJournal of Immunological Methods, 1984
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983